These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28317646)

  • 1. Clinical validity of delayed recall tests as a gateway biomarker for Alzheimer's disease in the context of a structured 5-phase development framework.
    Cerami C; Dubois B; Boccardi M; Monsch AU; Demonet JF; Cappa SF;
    Neurobiol Aging; 2017 Apr; 52():153-166. PubMed ID: 28317646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical validity of medial temporal atrophy as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework.
    Ten Kate M; Barkhof F; Boccardi M; Visser PJ; Jack CR; Lovblad KO; Frisoni GB; Scheltens P;
    Neurobiol Aging; 2017 Apr; 52():167-182.e1. PubMed ID: 28317647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Category Cued Recall test in very mild Alzheimer's disease: discriminative validity and correlation with semantic memory functions.
    Vogel A; Mortensen EL; Gade A; Waldemar G
    Eur J Neurol; 2007 Jan; 14(1):102-8. PubMed ID: 17222122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Memory evaluation with a new cued recall test in patients with mild cognitive impairment and Alzheimer's disease.
    Ivanoiu A; Adam S; Van der Linden M; Salmon E; Juillerat AC; Mulligan R; Seron X
    J Neurol; 2005 Jan; 252(1):47-55. PubMed ID: 15654553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construct validity of the Free and Cued Selective Reminding Test in older adults with memory complaints.
    Clerici F; Ghiretti R; Di Pucchio A; Pomati S; Cucumo V; Marcone A; Vanacore N; Mariani C; Cappa SF
    J Neuropsychol; 2017 Jun; 11(2):238-251. PubMed ID: 26560406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease.
    Wagner M; Wolf S; Reischies FM; Daerr M; Wolfsgruber S; Jessen F; Popp J; Maier W; Hüll M; Frölich L; Hampel H; Perneczky R; Peters O; Jahn H; Luckhaus C; Gertz HJ; Schröder J; Pantel J; Lewczuk P; Kornhuber J; Wiltfang J
    Neurology; 2012 Feb; 78(6):379-86. PubMed ID: 22238414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests.
    Matias-Guiu JA; Cortés-Martínez A; Valles-Salgado M; Rognoni T; Fernández-Matarrubia M; Moreno-Ramos T; Matías-Guiu J
    Int Psychogeriatr; 2017 Jan; 29(1):105-113. PubMed ID: 27682860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of an Integrated Analysis of Different Memory Tasks to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease: The Episodic Memory Score (EMS).
    Marra C; Gainotti G; Fadda L; Perri R; Lacidogna G; Scaricamazza E; Piccininni C; Quaranta D
    J Alzheimers Dis; 2016; 50(1):61-70. PubMed ID: 26639965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different deficit patterns on word lists and short stories predict conversion to Alzheimer's disease in patients with amnestic mild cognitive impairment.
    De Simone MS; Perri R; Fadda L; De Tollis M; Turchetta CS; Caltagirone C; Carlesimo GA
    J Neurol; 2017 Nov; 264(11):2258-2267. PubMed ID: 28948357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Memory performance on the story recall test and prediction of cognitive dysfunction progression in mild cognitive impairment and Alzheimer's dementia.
    Park JH; Park H; Sohn SW; Kim S; Park KW
    Geriatr Gerontol Int; 2017 Oct; 17(10):1603-1609. PubMed ID: 27910252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework.
    Mattsson N; Lönneborg A; Boccardi M; Blennow K; Hansson O;
    Neurobiol Aging; 2017 Apr; 52():196-213. PubMed ID: 28317649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual associations to retrieve episodic memory across healthy elderly, mild cognitive impairment, and patients with Alzheimer's disease.
    Meyer SRA; De Jonghe JFM; Schmand B; Ponds RWHM
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2019 May; 26(3):447-462. PubMed ID: 29768086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using virtual reality to characterize episodic memory profiles in amnestic mild cognitive impairment and Alzheimer's disease: influence of active and passive encoding.
    Plancher G; Tirard A; Gyselinck V; Nicolas S; Piolino P
    Neuropsychologia; 2012 Apr; 50(5):592-602. PubMed ID: 22261400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cued recall measure predicts the progression of gray matter atrophy in patients with amnesic mild cognitive impairment.
    Koric L; Ranjeva JP; Felician O; Guye M; de Anna F; Soulier E; Didic M; Ceccaldi M
    Dement Geriatr Cogn Disord; 2013; 36(3-4):197-210. PubMed ID: 23899504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modern scores for traditional tests - Review of the diagnostic potential of scores derived from word list learning tests in mild cognitive impairment and early Alzheimer's Disease.
    Schäfer S; Tröger J; Kray J
    Neuropsychologia; 2024 Aug; 201():108908. PubMed ID: 38744410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological predictors of conversion from mild cognitive impairment to Alzheimer's disease.
    Gainotti G; Quaranta D; Vita MG; Marra C
    J Alzheimers Dis; 2014; 38(3):481-95. PubMed ID: 24002185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework.
    Chiotis K; Saint-Aubert L; Boccardi M; Gietl A; Picco A; Varrone A; Garibotto V; Herholz K; Nobili F; Nordberg A;
    Neurobiol Aging; 2017 Apr; 52():214-227. PubMed ID: 28317650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of the five-word test for the evaluation of verbal episodic memory and dementia in a memory clinic setting.
    Mormont E; Jamart J; Robaye L
    J Geriatr Psychiatry Neurol; 2012 Jun; 25(2):78-84. PubMed ID: 22689699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recall and recognition of verbal paired associates in early Alzheimer's disease.
    Lowndes GJ; Saling MM; Ames D; Chiu E; Gonzalez LM; Savage GR
    J Int Neuropsychol Soc; 2008 Jul; 14(4):591-600. PubMed ID: 18577288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Meta-Analysis of fMRI Activation Differences during Episodic Memory in Alzheimer's Disease and Mild Cognitive Impairment.
    Terry DP; Sabatinelli D; Puente AN; Lazar NA; Miller LS
    J Neuroimaging; 2015; 25(6):849-60. PubMed ID: 26076800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.